Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses

MLA

Gui Chao Li, et al. “Adjuvant Chemoradiotherapy versus Adjuvant Chemotherapy for Patients with N3 Gastric Cancer after D2/R0 Resection: A Retrospective Study Based on Propensity Score Analyses.” Cancer Management and Research, May 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e3e3ffc1bfdbbf980122457d789f9b16&authtype=sso&custid=ns315887.

APA

Gui Chao Li, Yan Wang, Ran Hu, Meng Long Zhou, Ya Qi Wang, Miao Mo, Wang Yang, Zhen Zhang, Jia Ning Yang, & Y. Wang. (2019). Adjuvant chemoradiotherapy versus adjuvant chemotherapy for patients with N3 gastric cancer after D2/R0 resection: a retrospective study based on propensity score analyses. Cancer Management and Research.

Chicago

Gui Chao Li, Yan Wang, Ran Hu, Meng Long Zhou, Ya Qi Wang, Miao Mo, Wang Yang, Zhen Zhang, Jia Ning Yang, and Y. Wang. 2019. “Adjuvant Chemoradiotherapy versus Adjuvant Chemotherapy for Patients with N3 Gastric Cancer after D2/R0 Resection: A Retrospective Study Based on Propensity Score Analyses.” Cancer Management and Research, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e3e3ffc1bfdbbf980122457d789f9b16&authtype=sso&custid=ns315887.